FOLR1 and ovarian carcinoma: A multivariate analysis of known prognostic factors in ovarian cancer (pathological type and grade, FIGO stage, macroscopic disease) revealed no association between FOLR1 mRNA expression and survival at 6 months, 12 months, or more than 12 months.